Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
Background<br/> Multiple sclerosis (MS) is an inflammatory and neurodegenerative disorder of the central nervous system (CNS). Reliable biomarkers are urgently needed for its diagnosis and management, and as clues to its pathogenesis, in which EBV is implicated. <br/><br/> Objecti...
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
Elsevier
2017
|